Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Sales revenue	$ 0	$ 0	$ 0	$ 0
Cost of goods sold	0	0	0	0
Gross profit	0	0	0	0
General and administrative expenses	275,839	411,545	735,357	904,951
LOSS FROM OPERATIONS	(275,839)	(411,545)	(735,357)	(904,951)
OTHER INCOME/(EXPENSE)
Interest expense	(37,218)	(95,244)	(75,789)	(160,498)
Other income	0	9,000	0	9,000
Total other expense	(37,218)	(86,244)	(75,789)	(151,498)
LOSS BEFORE INCOME TAXES	(313,057)	(497,789)	(811,146)	(1,056,449)
Income tax expense	0	0	0	0
LOSS FROM CONTINUING OPERATIONS	(313,057)	(497,789)	(811,146)	(1,056,449)
Loss from discontinued operations	0	(58,067)	0	(131,823)
NET LOSS	(313,057)	(555,856)	(811,146)	(1,188,272)
Net loss attributable to common stockholders of GB Sciences, Inc. - basic and diluted
Continuing operations	(313,057)	(497,789)	(811,146)	(1,056,449)
Discontinued operations	0	(58,067)	0	(131,823)
Net loss	$ (313,057)	$ (555,856)	$ (811,146)	$ (1,188,272)
Net loss per common share – basic and diluted
Continuing operations (in dollars per share)	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Discontinued operations (in dollars per share)	0	(0.00)	0	(0.00)
Net loss (in dollars per share)	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common shares outstanding - basic and diluted (in shares)	346,269,298	317,429,078	336,062,449	316,557,100